{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:08:34Z","timestamp":1776323314879,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1016\/s0920-9964(99)00095-x","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T01:49:08Z","timestamp":1027648148000},"page":"7-17","source":"Crossref","is-referenced-by-count":226,"title":["Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients"],"prefix":"10.1016","volume":"42","author":[{"given":"Jeffrey K","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravinder D","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0920-9964(99)00095-X_REF1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0378-4347(89)80024-6","article-title":"A new rapid method for phospholipid separation by high-performance liquid chromatography with light-scattering detection","volume":"497","author":"Breton","year":"1989","journal-title":"J. Chromatogr."},{"key":"10.1016\/S0920-9964(99)00095-X_REF2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-2275(20)34367-4","article-title":"Rapid separation and quantification of lipid classes by high-performance liquid chromatography and mass (light-scattering) detection","volume":"26","author":"Christie","year":"1985","journal-title":"J. Lipid Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0952-3278(92)90061-M","article-title":"Inositol phoslipid turnover in platelet of schizophrenic patients","volume":"46","author":"Das","year":"1992","journal-title":"Prostagland. Leukotr. Essent. Fatty Acids"},{"key":"10.1016\/S0920-9964(99)00095-X_REF4","first-page":"46A","article-title":"31Phosphorus MRSI in the frontal and parietal lobes in schizophrenia","volume":"33","author":"Deicken","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0920-9964(94)00036-8","article-title":"Correlation between left frontal phospholipids and Wisconsin Card Sort Test performance in schizophrenia","volume":"14","author":"Deicken","year":"1995","journal-title":"Schizophr. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0952-3278(92)90058-Q","article-title":"Increased concentrations of phosphatidyl-inositol and decreased esterification of arachidonic acid into phospholipids in platelets from patients with schizoaffective disorders or atypic phasic psychoses","volume":"46","author":"Demisch","year":"1992","journal-title":"Prostagland. Leukotr. Essent. Fatty Acids"},{"key":"10.1016\/S0920-9964(99)00095-X_REF7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0006-8993(91)91296-D","article-title":"The effect of typical and atypical antipsychotic drugs on the stimulation of phosphoinositide hydrolysis produced by the 5-HT3 receptor agonist 2-methyl-serotonin","volume":"545","author":"Edwards","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0006-3223(90)90481-G","article-title":"The platelet phosphoinositide system in schizophrenia: The effects of neuroleptic treatment","volume":"28","author":"Essali","year":"1990","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF9","first-page":"925","article-title":"Actions of neuroleptics on the acetylcholine-induced phospholipid effect in rat neostriatal homogenates","volume":"20","author":"Friedel","year":"1981","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0920-9964(99)00095-X_REF10","first-page":"204A","article-title":"31P magnetic resonance spectroscopy of schizophrenic patients with neuroleptic-resistant positive and negative symptoms","volume":"31(S)","author":"Fukuzako","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0278-5846(96)00036-X","article-title":"Phosophorus magnetic resonance spectroscopy in schizophrenia: Correlation between membrane phospholipid metabolism in temporal lobe and positive symptoms","volume":"20","author":"Fukuzako","year":"1996","journal-title":"Prog. Neuropsychopharma. Biol. Psychiary"},{"key":"10.1016\/S0920-9964(99)00095-X_REF12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0006-3223(87)90164-8","article-title":"Increased plasma phospholipase-A2 activity in schizophrenic patients: Reduction after neuroleptic therapy","volume":"22","author":"Gattaz","year":"1987","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-3223(92)90211-H","article-title":"Phospholipase A2 in schizophrenia","volume":"31","author":"Gattaz","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0920-9964(94)90084-1","article-title":"A red cell membrane abnormality in a sub-group of schizophrenic patients: Evidence for two diseases","volume":"12","author":"Glen","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0952-3278(96)90139-8","article-title":"Membrane fatty acids, niacin flushing and clinical parameters","volume":"55","author":"Glen","year":"1996","journal-title":"Prostaglandins Leukotr. Essent. Fatty Acids"},{"key":"10.1016\/S0920-9964(99)00095-X_REF16","first-page":"54","article-title":"Schizophrenia: A biochemical disorder","volume":"32","author":"Horrobin","year":"1980","journal-title":"Biomedicine"},{"key":"10.1016\/S0920-9964(99)00095-X_REF17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0006-3223(91)90235-E","article-title":"Fatty acid levels in the brains of schizophrenics and normal controls","volume":"30","author":"Horrobin","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0306-9877(95)90246-5","article-title":"Possible relevance of phospholipid abnormalities and genetic interactions in psychiatric disorders: The relationship between dyslexia and schizophrenia","volume":"45","author":"Horrobin","year":"1995","journal-title":"Med. Hypotheses"},{"key":"10.1016\/S0920-9964(99)00095-X_REF19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0952-3278(96)90138-6","article-title":"Schizophrenia as a membrane lipid disorder which is expressed throughout the body","volume":"55","author":"Horrobin","year":"1996","journal-title":"Prostagland. Leukotr. Essent. Fatty Acids"},{"key":"10.1016\/S0920-9964(99)00095-X_REF20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0006-3223(89)90216-3","article-title":"Essential fatty acids in plasma phospholipids in schizophrenics","volume":"25","author":"Horrobin","year":"1989","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0006-3223(96)00112-6","article-title":"The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia?","volume":"41","author":"Hudson","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/ajp.143.8.993","article-title":"Prevalence of smoking among psychiatric outpatients","volume":"143","author":"Hughes","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1471-4159.1994.62010180.x","article-title":"Agonist-induced, GTP-dependent phosphoinositide hydrolysis in postmortem human brain membranes","volume":"62","author":"Jope","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/S0920-9964(99)00095-X_REF24","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1046\/j.1471-4159.1996.66062402.x","article-title":"The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain","volume":"66","author":"Jope","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/S0920-9964(99)00095-X_REF25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1471-4159.1998.70020763.x","article-title":"Selective increases in phosphoinositide signaling activity and G protein levels in postmortem brain from subjects with schizophrenia or alcohol dependence","volume":"70","author":"Jope","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/S0920-9964(99)00095-X_REF26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0006-3223(91)90291-S","article-title":"Essential and other fatty acids in plasma in schizophrenics and normal individuals from Japan","volume":"30","author":"Kaiya","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-1781(93)90032-C","article-title":"Erythrocyte membrane phospholipids in psychotic patients","volume":"49","author":"Keshaven","year":"1993","journal-title":"Psychiatr. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF28","first-page":"45A","article-title":"Are membrane phospholipid changes in schizophrenia familial?","volume":"33","author":"Keshaven","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0006-3223(93)90174-C","article-title":"Biological stability of MRNA isolated from human postmortem brain collections","volume":"33","author":"Leonard","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/10826079208017168","article-title":"A rapid method for phospholipid class separation by HPLC using an evaporative light-scattering detector","volume":"15","author":"Letter","year":"1992","journal-title":"J. Liquid Chromatogr."},{"key":"10.1016\/S0920-9964(99)00095-X_REF31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF02245510","article-title":"Effects of chronic nicotine and haloperidol administration on muscarinic receptor-mediated phosphoinositide turnover in rat brain slices","volume":"109","author":"Li","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0920-9964(99)00095-X_REF32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/BF00967705","article-title":"Effect of chronic haloperidol treatment on dopamine-induced inositol phosphate formation in rat brain slices","volume":"19","author":"Li","year":"1994","journal-title":"Neurochem. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0920-9964(94)90048-5","article-title":"Distribution of plasma membrane phospholipids and cholesterol in skin fibroblasts from drug-naive patients at the onset of psychosis","volume":"13","author":"Mahadik","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0952-3278(96)90150-7","article-title":"Essential fatty acids and abnormal involuntary movements in the general male population: a study of men born in 1933","volume":"55","author":"Nilsson","year":"1996","journal-title":"Prostagland. Leukotr. Essent. Fatty Acids"},{"key":"10.1016\/S0920-9964(99)00095-X_REF35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0006-3223(93)90157-9","article-title":"Elevated PLA2 activity in schizophrenics and other psychiatric patients","volume":"34","author":"Noponen","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3223(96)00302-2","article-title":"Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers","volume":"42","author":"Olincy","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0006-8993(91)90042-T","article-title":"Assay of a phosphatidylinositol bisphosphate phospholipase C activity in postmortem human brain","volume":"543","author":"O'Neill","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0301-0082(96)00035-4","article-title":"Phosphoinositide signaling in human brain","volume":"50","author":"Pacheco","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/S0920-9964(99)00095-X_REF39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0022-3956(95)00001-L","article-title":"Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients","volume":"29","author":"Peet","year":"1995","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0952-3278(96)90148-9","article-title":"Essential fatty acid deficiency in eyrthrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation","volume":"55","author":"Peet","year":"1996","journal-title":"Prostagland. Leukotr. Essent. Fatty Acids"},{"key":"10.1016\/S0920-9964(99)00095-X_REF41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/archpsyc.1991.01810300075011","article-title":"Alterations in brain high energy phosphate and membrane phospholipid metabolism in first episode drug na\u0131\u0308ve schizophrenics","volume":"48","author":"Pettegrew","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/S0920-9964(99)00095-X_REF42","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/schbul\/19.1.35","article-title":"31P nuclear magnetic resonance spectroscopy: Neurodevelopment and schizophrenia","volume":"19","author":"Pettegrew","year":"1993","journal-title":"Schizophr. Bull."},{"key":"10.1016\/S0920-9964(99)00095-X_REF43","unstructured":"Reddy, R.D., Yao, J.K., in press. Schizophrenia: Role of oxidative stress and essential fatty acids. In: Temple and Basn (Eds.), Antioxidants and Disease."},{"key":"10.1016\/S0920-9964(99)00095-X_REF44","series-title":"Psychopharmacology. The Third Generation on Progress","first-page":"759","article-title":"Phospholipid and prostaglandin hypotheses of schizophrenia","author":"Rotrosen","year":"1987"},{"key":"10.1016\/S0920-9964(99)00095-X_REF45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0925-4927(94)90016-7","article-title":"Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia","volume":"55","author":"Shioiri","year":"1994","journal-title":"Psychiatr. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0920-9964(94)90044-2","article-title":"Membrane phospholipid metabolism and schizophrenia: an in vivo 31P MR spectroscopy study","volume":"13","author":"Stanley","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF47","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1471-4159.1991.tb03466.x","article-title":"Membrane lipids in the aging human brain","volume":"56","author":"Svennerholm","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/S0920-9964(99)00095-X_REF48","series-title":"Lipids, Health and Behavior","first-page":"197","article-title":"Brain lipids and diet","author":"Tacconi","year":"1997"},{"key":"10.1016\/S0920-9964(99)00095-X_REF49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0165-1781(89)90146-7","article-title":"A double blind trial of essential fatty acid supplementation in patients with tardive dyskinesia","volume":"27","author":"Vaddadi","year":"1989","journal-title":"Psychiatr. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0952-3278(96)90151-9","article-title":"Dyskinesias and their treatment with essential fatty acids: a review","volume":"55","author":"Vaddadi","year":"1996","journal-title":"Prostagland. Leukotr. Essent. Fatty Acids"},{"key":"10.1016\/S0920-9964(99)00095-X_REF51","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1523\/JNEUROSCI.15-05-03679.1995","article-title":"Arachidonic acid as a possible negative feedback inhibitor of nicotinic acetylcholine receptors on neurons","volume":"15","author":"Vijayaraghavan","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/S0920-9964(99)00095-X_REF52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01474676","article-title":"Transmembrane signalling through phospholipase C in human cortical membranes","volume":"18","author":"Wallace","year":"1993","journal-title":"Neurochem. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF53","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archpsyc.1991.01810300090013","article-title":"Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls","volume":"48","author":"Williamson","year":"1991","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/S0920-9964(99)00095-X_REF54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0952-3278(92)90057-P","article-title":"Increased turnover of platelet phosphatidylinositol in schizophrenia","volume":"46","author":"Yao","year":"1992","journal-title":"Prostagland. Leukotr. Essent. Fatty Acids"},{"key":"10.1016\/S0920-9964(99)00095-X_REF55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0920-9964(94)90014-0","article-title":"Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidity","volume":"11","author":"Yao","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF56","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0920-9964(94)90046-9","article-title":"Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures","volume":"13","author":"Yao","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0165-1781(94)90061-2","article-title":"Platelet aggregation and secretion in schizophrenia","volume":"54","author":"Yao","year":"1994","journal-title":"Psychiatr. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0920-9964(94)90045-0","article-title":"Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition","volume":"13","author":"Yao","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0952-3278(96)90141-6","article-title":"Incorporation of [3H]arachidonic acid into platelet phospholipids of patients with schizophrenia","volume":"55","author":"Yao","year":"1996","journal-title":"Prostagland. Leukotr. Essent. Fatty Acids"},{"key":"10.1016\/S0920-9964(99)00095-X_REF60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-1781(95)02832-3","article-title":"Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia","volume":"60","author":"Yao","year":"1996","journal-title":"Psychiatr. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF61","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-1781(96)02862-4","article-title":"A decreased serotonergic responsivity in platelets of unmedicated patients with schizophrenia","volume":"63","author":"Yao","year":"1996","journal-title":"Psychiatr. Res."},{"key":"10.1016\/S0920-9964(99)00095-X_REF62","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF00652246","article-title":"A cell membrane correlate of tardive dyskinesia in patients treated with phenothiazines","volume":"88","author":"Zubenko","year":"1986","journal-title":"Psychopharmacology"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099649900095X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099649900095X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:05:52Z","timestamp":1620965152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099649900095X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S092099649900095X"],"URL":"https:\/\/doi.org\/10.1016\/s0920-9964(99)00095-x","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}